The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT)

Seminars in Oncology

Volumn 31, Issue SUPPL. 18, 2004, Pages 2-7

  Suntharalingam, Mohan ^a,b   Jaboin, Jerry ^a   Taylor, Rodney ^a   Wolf, Jeffrey ^a   Banglore, Madan ^a   Van Echo, David ^a   Ord, Robert ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; CARBOPLATIN; PACLITAXEL;

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL PROTECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEHYDRATION; DERMATITIS; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; DYSPHAGIA; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; HYPOTENSION; LARYNX CARCINOMA; LEUKOPENIA; LYMPH NODE METASTASIS; MALE; MOUTH CARCINOMA; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; OROPHARYNX CARCINOMA; PATIENT MONITORING; PHARYNX CARCINOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; SEX RATIO; SKIN MANIFESTATION; SQUAMOUS CELL CARCINOMA; XEROSTOMIA;

EID: 13844294262     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2005.02.001     Document Type: Conference Paper

References (25)

1. M. Al-Sarraf, T.F. Pajak, V.A. Marcial Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG Study Cancer 59 1987 259 265
2. E.E. Vokes, I. Athanasiadis Chemotherapy of squamous cell carcinoma of head and neck The future is now Ann Oncol 7 1996 15 29
3. J.P. Pignon, J. Bourhis, C. Domenge Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer Lancet 355 2000 949 955
4. K.K. Ang Altered fractionation in the management of head and neck cancer Int J Radiat Biol 73 1998 395 399
5. J.L. Lefebvre, D. Chevalier, B. Luboinski EORTC Head and Neck Cancer Cooperative Group Larynx preservation in pyriform sinus cancer Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial J Natl Cancer Inst 88 1996 890 899
6. M. Al-Sarraf, M. LeBlanc, P.G. Giri Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer Phase III randomized Intergroup study 0099 J Clin Oncol 16 1998 1310 1317
7. D.J. Haraf, M. Kies, A.W. Rademaker Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer J Clin Oncol 17 1999 638 644
8. P. Kumar, K.T. Robbins Treatment of advanced head and neck cancer with intra-arterial cisplatin and concurrent radiation therapy The 'RADPLAT' Protocol Curr Oncol Rep 3 2001 59 65
9. T.G. Wendt, G.G. Grabenbauer, C.M. Rodel Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer A randomized multicenter study J Clin Oncol 16 1998 1318 1324
10. M. Suntharalingam, M.L. Haas, B.A. Conley The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck Int J Radiat Oncol Biol Phys 47 2000 49 56
11. R.L. Capizzi, W. Oster Protection of normal tissue from the cytotoxic effects of chemotherapy and radiation by amifostine Clinical experiences Eur J Cancer 31A SUPPL. 1 1995 S8 S13
12. R.L. Capizzi, W. Oster Chemoprotective and radioprotective effects of amifostine An update of clinical trials Int J Hematol 72 2000 425 435
13. C.W. Taylor, L.M. Wang, A.F. List Amifostine protects normal tissues from paclitaxel toxicity while cytotoxicity against tumour cells is maintained Eur J Cancer 33 1997 1693 1698
14. R. Capizzi Amifostine The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies Semin Oncol 23 1996 2 17
15. P.B. Chougule, M.S. Akhtar, W. Akerley Chemoradiotherapy for advanced inoperable head and neck cancer A phase II study Semin Radiat Oncol 9 1999 58 63
16. D.M. Brizel, M.E. Albers, S.R. Fisher Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer N Engl J Med 338 1998 1798 1804
17. W.F. Regine, J. Valentino, S.M. Arnold High-dose intra-arterial cisplatin boost with hyperfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck J Clin Oncol 19 2001 3333 3339
18. J. Bourhis, J.P. Pignon Meta-analyses in head and neck squamous cell carcinoma. What is the role of chemotherapy? Hematol Oncol Clin North Am 13 1999 769 775
19. E.B. Douple, R.C. Richmond, J.A. O'Hara Carboplatin as a potentiator of radiation therapy Cancer Treat Rev 12 SUPPL. A 1985 111 124
20. G. Calais, O. Le Floch Concomitant radiotherapy and chemotherapy in the treatment of cancers of the upper respiratory and digestive tracts Bull Cancer Radiother 83 1996 321 329
21. A.S. Garden, E.E. Vokes, A.A. Forastiere Preliminary results of RTOG 9703-A phase II randomized trial of concurrent radiation (RT) and chemotherapy for advanced squamous cell carcinomas of the head and neck Proc Am Soc Clin Oncol 20 2001 223 (abstr 891)
22. D. Brizel, T. Wasserman The influence of intravenous amifostine on xerostomia and survival during radiotherapy for head and neck cancer Two year follow up of a prospective randomized trial Proc Am Soc Clin Oncol 23 2004 495 (abstr 5536)
23. D.M. Brizel, T.H. Wasserman, M. Henke Phase III randomized trial of amifostine as a radioprotector in head and neck cancer J Clin Oncol 18 2000 3339 3345
24. P.R. Anne, W.J. Curran A phase II trial of subcutaneous amifostine and radiation therapy in patients with head and neck cancer Semin Radiat Oncol 12 2002 18 19
25. M.I. Koukourakis, G. Kyrias, S. Kakolyris Subcutaneous administration of amifostine during fractionated radiotherapy A randomized phase II study J Clin Oncol 18 2000 2226 2233